Japanese Pharmaceutical Industry: An Analysis

June 19, 2007 - PRLog -- This report assesses the market potential, growth opportunities and competitive scenario of the Japanese pharmaceutical industry.

With around 11% of the global share of the pharmaceutical market, growth of the Japanese pharmaceutical industry is driven by an increase in the proportion of the aged in the population mix. While the government is encouraging domestic companies to opt for cost-cutting strategies like contract manufacturing, the favorable foreign investment scenario has resulted into dominance of foreign-affiliated companies that control 33% of the total prescription drug market.

This report analyzes the pharmaceutical sector in Japan and closely examines the emerging trends. It also presents the competitive landscape in which leading companies like Takeda Pharmaceutical, Daiichi Sankyo, Astellas and Pfizer are competing for a share of the Japanese pharma market.

Table of Contents

1. Introduction

1.1 Industry Definition
1.2 Industry Segments
2. Market Dynamics

2.1 Market Overview
2.2 Factors That Have Driven Change
2.3 Major Issues & Implications
3. Industry Growth and Events

3.1 Trend Analysis
3.2 Growth Opportunities
3.3 Competitve Forces
4. PEST Analysis

4.1 Political Factors
4.2 Economic Factors
4.3 Social Factors
4.4 Technological Factors
5. Michael Porter's Five Forces Analysis

5.1 Buyers'/Customers' Power
5.2 Suppliers' Power
5.3 Rivalry among Competitors
5.4 Threat of New Entrants
5.5 Threat of Substitutes
6. Leading Companies in the Industry

6.1 Financial Highlights
6.2 Market Capitalization
6.3 Revenues and Net Income Comparison
6.4 Stock Watch
6.5 Analysis of Strategies
7. Outlook

Appendix I: International Conferences and Annual Meetings
Appendix II: Industry Associations and Organizations

For more information, Please visit :
http://www.bharatbook.com/bookdetail.asp?bookid=25255&pub...=

Website: www.bharatbook.com